Differences in influenza vaccine effectiveness by sex among adults hospitalized with acute respiratory illness-IVY network, January 24, 2022-September 1, 2024

Author Department

Medicine

Document Type

Article, Peer-reviewed

Publication Date

1-2026

Abstract

This analysis assessed differences in influenza vaccine effectiveness (VE) and severe in-hospital outcomes between U.S. male and female adults hospitalized with laboratory-confirmed influenza in a multi-center network during 2022-2024. Compared with men, women hospitalized with influenza were less likely to smoke (21.5 % vs 25.3 %, P = 0.02), to have COPD (21.9 % vs 22.7 %, P < 0.001), and to be admitted to an intensive care unit once hospitalized (17.3 % vs 20.7 %, P = 0.04). Influenza VE (95 % confidence interval [CI]) was significantly higher in women aged ≥50 years compared with men aged ≥50 years (48.5 % [39.2 %-56.4 %] vs 26.2 % [13.0 %-37.5 %]). VE was slightly lower in women aged 18-49 years compared with women ≥50 years (46.2 % [95 % CI: 24.2 %-61.8 % vs 61.3 % [41.0 %-74.6 %]) but significantly lower in men aged ≥50 years compared with men aged 18-49 years (61.3 % [41.0 %-74.6 %] vs 26.2 % [13.0 %-37.5 %]). Disaggregation of sex should be considered in future influenza VE studies.

Keywords: Hospitalization; Immune response; Influenza; Sex differences; Vaccine effectiveness.

PMID

41518970

Share

COinS